期刊文献+

伊贝沙坦对急性心肌梗死后左室重塑影响

Effects of Irbesartan on the Left Ventricular Remodeling Following Acute Myocardial Infarction
下载PDF
导出
摘要 目的 观察伊贝沙坦对急性心肌梗死 (AMI)后左室重塑的阻抑作用。方法 将 72例 AMI患者随机分为常规治疗组 36例、伊贝沙坦治疗组 36例 ,并于 AMI后 2、2 4周分别进行超声心动图和平衡法核素心室造影 ,测定左室心肌重量、左室收缩功能和舒张功能 ,了解伊贝坦对 AMI后左室重塑的阻抑作用。结果  AMI后 2 4周时伊贝沙坦与常规治疗组比较室间隔厚度、左室后壁厚度、左室舒张末内径和左室心肌重量指数均明显降低 (P<0 .0 5 ,或 P<0 .0 0 1)。AMI后 2 4周时 ,伊贝沙坦治疗组与对照组比较左室射血分数明显增加 (P <0 .0 5 ) ,左室峰射血率和左室峰射血率时间均显著下降 (P<0 .0 5 ) ,同时左室高峰充盈率明显升高 (P<0 .0 5 ) ,左室高峰充盈率时间显著下降 (P<0 .0 0 1)。结论 伊贝沙坦能明显减轻心肌梗死后心肌肥厚和左室重塑 ,改善左室功能。 Objective To observe the inhibitory effects of irbesartan on left ventricular remodeling(LVRM)after acute myocardial infarction(AMI) Methods 72 patients with AMI were randomized divided into the conventional treatment group(36 patients) and irbeasartan treatment group(36 patients).At 2nd and 24th week after AMI,the left ventricular myocardium weight were measured by echocardiogram,and the parameters of left venticular systolic and diastolic function were measured by equilibrium radionuclide angiography.Results At 24th week,LVEF,LPER and LPFR in irbesartan treatment group were significantly increased(P<0.05)as comared with those in conventional treatment group,res pectively.LTPER and LTPFR in irbesartan group were decreased (P<0.05,or P<0.001) as compared with the conventional treatment group,respectively.Conclusion Irbesartan could significantly reduce myocardial hypetrtophy and LV RM following AMI,thus improve the left ventricular systolic function.
出处 《中国误诊学杂志》 CAS 2002年第8期1137-1139,共3页 Chinese Journal of Misdiagnostics
关键词 伊贝沙坦 AMI 阻抑作用 急性心肌梗死 左室重塑 Ventricular,remodeling Myocardium infarction Lrbesar tan
  • 相关文献

参考文献9

  • 1陈金良,傅向华,马宁,李显平,刘保国,柴锡庆.溶栓前肝素治疗对急性心肌梗死后左室重构的影响[J].中国危重病急救医学,2001,13(3):164-166. 被引量:15
  • 2Walsh JT,Batin PD,Hawkins M,et al.Ventricular dilatation in the absence of ACE inhibiotrs:influence of haemodynamic and neurohormonal variables following myocardial infarction.Heart,1999,81(1):33-39
  • 3马中富,叶任高,罗斌,何建桂,马虹,高劲松.p53和Bcl-2基因mRNA在老年急性心肌梗死猝死者心肌细胞凋亡中作用的研究[J].中国危重病急救医学,2001,13(10):593-597. 被引量:10
  • 4Taylor K,Patten RD,Smith JJ,et al.Divergent effects of angiotensin-converting enzyme inhibition and angiotensin Ⅱ receptor antagonism on myocardial cellular proliferetion and collagen deposition after myocardial infarction in rats.J Cardiovasc Pharmacol,1998,31(5):654-668
  • 5Andreas J,Rainer S,Hilmar D,et al.Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation,bradykinin and prostaglandins in pigs.J Am Coll Cardiol,1998,32(5):1787-1796
  • 6Richer C,Fornes P,Cazaubon C,et al.Effects of long-term angiotension Ⅱ AT1 receptor block-ade in survival,hemodynamics and cardiac remodeling in chronic heart failure in rats.Cardiovasc Res,1999,41(1):100-108
  • 7Ambrose J,Pribnow DG,Girand GD,et al.Angiotensin type 1 receptor antagonism with irbesavtan inhibits ventricular hypertrophy and improved diastolic function in the remodeling post-myocardial infarction ventricle.J Am Soc Nephrol,1999,10(3):129-136
  • 8Pitt B,Poole-Wilson PA.Segal R,et al.Effect of losartan compared with captopril in mortality in patients with symptomatic heart failure:randomised trial:the losartan heart failure survival study ELITE H.Lancet,2000,355(9215):1582-1587
  • 9Asano K,Dutcher DL,Port JD,et al.Selective down regulation of the angiotensin Ⅱ At1-receptor subtype in failing human ventricular myocardium.Circulation,1997,95(5):1193-1200

二级参考文献8

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部